Investors
We maintain a transparent, comprehensive dialogue with the financial community about our strategy, outlook, financial data, economic environment, and social impact.
First quarter 2026
Q1 2026 results were reviewed by management during a live audio webcast with the financial community on April 23, 2026. The presentation was followed by a Q&A session.
Press Releases
Upcoming Events
12May
Berenberg Pharma R&D Back to the Future l Boston
Speakers: Alyssa Johnsen, SVP, Global Therapeutic Area Head for Immunology & Oncology Development, and Mike Quigley, Chief Scientific Officer, and Head of Research
Conferences
13May
Rothschild & Co’s Global Equities Conference l Toronto
Conferences
19May
Oddo Bhf 20th Sustainability Forum l Paris
Speaker : Laurent Lhopitallier, Head of ESG Performance
Conferences
31st Consecutive Year of Dividend Increase
Environment, Social, Governance
As a global pharmaceutical company, we stretch everyday to deliver safe and sustainable innovation and play our part in addressing some of the world’s most pressing challenges.
Contact Our Investor Relations Team
For general inquiries
Please contact the switchboard, +33 (0)1 53 77 40 00